Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the ...

A liberal transfusion strategy following major vascular or general surgery did not significantly improve outcomes at 90 days post procedure in patients at high risk of a cardiac event when compared to ...

We are a young, vibrant section dedicated to adding value to Section members interested in Innovation across the cardiovascular spectrum. Our section is member-driven and focused on all aspects of ...

Interventional cardiology will be in the spotlight during TCT 2025 in San Francisco and amongst the Featured Clinical Research are presentations looking at outcomes in patients following coronary ...

From coffee to tea, caffeinated beverages are an integral part of morning routines across the globe, but these popular drinks can be harmful when enjoyed in excess. According to a new study being ...

More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and death, according to a study in JACC, the flagship journal of the American ...

A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, according to the new Global Burden of Disease (GBD) special report ...

A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to men of a similar age and health profile, according to new findings presented at the American ...

The researchers used data from the 2020 U.S. Census Bureau report for the years 2025 to 2060, and combined these census counts with the prevalence of cardiovascular risk factors or disease based on ...

Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early cardiovascular events in the first five-years postpartum, according to a new study ...

In this episode, Clyde W. Yancy, MD, MSc, MACC, and Leslie L. Davis, NP, PhD, FACC, discuss the 2023 ACC Expert Consensus Decision Pathway on Management of Patients with HFpEF, and where to consider ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...